Sotera Health Co Stock Price To Earnings To Growth
| SHC Stock | USD 13.95 0.27 1.97% |
Sotera Health Co fundamentals help investors to digest information that contributes to Sotera Health's financial success or failures. It also enables traders to predict the movement of Sotera Stock. The fundamental analysis module provides a way to measure Sotera Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sotera Health stock.
Sotera |
Sotera Health Co Company Price To Earnings To Growth Analysis
Sotera Health's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Current Sotera Health Price To Earnings To Growth | 1.41 X |
Most of Sotera Health's fundamental indicators, such as Price To Earnings To Growth, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sotera Health Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
| Competition |
Based on the latest financial disclosure, Sotera Health Co has a Price To Earnings To Growth of 1.4146 times. This is 99.24% higher than that of the Life Sciences Tools & Services sector and 161.24% lower than that of the Health Care industry. The price to earnings to growth for all United States stocks is 71.07% higher than that of the company.
Sotera Price To Earnings To Growth Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sotera Health's direct or indirect competition against its Price To Earnings To Growth to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sotera Health could also be used in its relative valuation, which is a method of valuing Sotera Health by comparing valuation metrics of similar companies.Sotera Health is currently under evaluation in price to earnings to growth category among its peers.
Sotera Fundamentals
| Return On Equity | 0.17 | ||||
| Return On Asset | 0.0768 | ||||
| Profit Margin | 0.06 % | ||||
| Operating Margin | 0.32 % | ||||
| Current Valuation | 5.95 B | ||||
| Shares Outstanding | 283.24 M | ||||
| Shares Owned By Insiders | 2.46 % | ||||
| Shares Owned By Institutions | 94.71 % | ||||
| Number Of Shares Shorted | 6.9 M | ||||
| Price To Earning | 61.32 X | ||||
| Price To Book | 8.28 X | ||||
| Price To Sales | 3.46 X | ||||
| Revenue | 1.05 B | ||||
| Gross Profit | 618.01 M | ||||
| EBITDA | 420.2 M | ||||
| Net Income | 51.38 M | ||||
| Cash And Equivalents | 140.21 M | ||||
| Cash Per Share | 0.50 X | ||||
| Total Debt | 2.33 B | ||||
| Debt To Equity | 2.89 % | ||||
| Current Ratio | 2.81 X | ||||
| Book Value Per Share | 1.66 X | ||||
| Cash Flow From Operations | (147.73 M) | ||||
| Short Ratio | 6.62 X | ||||
| Earnings Per Share | 0.25 X | ||||
| Price To Earnings To Growth | 1.41 X | ||||
| Target Price | 16.19 | ||||
| Number Of Employees | 3 K | ||||
| Beta | 2.08 | ||||
| Market Capitalization | 3.87 B | ||||
| Total Asset | 3.13 B | ||||
| Retained Earnings | (654.44 M) | ||||
| Working Capital | 326.59 M | ||||
| Net Asset | 3.13 B |
About Sotera Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sotera Health Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sotera Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sotera Health Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Sotera Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sotera Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sotera Health Co Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sotera Health Co Stock:Check out Sotera Health Piotroski F Score and Sotera Health Altman Z Score analysis. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sotera Health. If investors know Sotera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sotera Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Sotera Health is measured differently than its book value, which is the value of Sotera that is recorded on the company's balance sheet. Investors also form their own opinion of Sotera Health's value that differs from its market value or its book value, called intrinsic value, which is Sotera Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sotera Health's market value can be influenced by many factors that don't directly affect Sotera Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sotera Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sotera Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sotera Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.